Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Eide

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemiaThomas O'Hare, Michael W N Deininger, Christopher A Eide, et al.
Developmental Biology|September 14, 2007
GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesisGokhan Dalgin, Devorah C Goldman, Nathan Donley, et al.
Haematologica|December 30, 2020
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemiaAlisa Damnernsawad, Daniel Bottomly, Stephen E Kurtz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2019
Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemiaAnupriya Agarwal, William J Bolosky, David B Wilson, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Bioinformatics (Oxford, England)|January 11, 2013
HitWalker: variant prioritization for personalized functional cancer genomicsDaniel Bottomly, Beth Wilmot, Jeffrey W Tyner, et al.
Precision Oncogenomics|August 29, 2025
Identifying Drug Combination Strategies for <i>ZMYM2: FGFR1</i> Fusion Positive LeukemiaAriane Huang, Sofia R Beer, Christopher A Eide, et al.
Plos One|November 1, 2008
Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugateC James Chou, Thomas O'Hare, Sophie Lefebvre, et al.
Leukemia|August 8, 2018
Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Pediatric Blood & Cancer|April 15, 2017
Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell lineJacob J Henderson, Jacob P Wagner, Nicolle E Hofmann, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemiaThomas O'Hare, Michael W N Deininger, Christopher A Eide, et al.
Developmental Biology|September 14, 2007
GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesisGokhan Dalgin, Devorah C Goldman, Nathan Donley, et al.
Haematologica|December 30, 2020
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemiaAlisa Damnernsawad, Daniel Bottomly, Stephen E Kurtz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2019
Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemiaAnupriya Agarwal, William J Bolosky, David B Wilson, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Bioinformatics (Oxford, England)|January 11, 2013
HitWalker: variant prioritization for personalized functional cancer genomicsDaniel Bottomly, Beth Wilmot, Jeffrey W Tyner, et al.
Precision Oncogenomics|August 29, 2025
Identifying Drug Combination Strategies for <i>ZMYM2: FGFR1</i> Fusion Positive LeukemiaAriane Huang, Sofia R Beer, Christopher A Eide, et al.
Plos One|November 1, 2008
Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugateC James Chou, Thomas O'Hare, Sophie Lefebvre, et al.
Leukemia|August 8, 2018
Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Pediatric Blood & Cancer|April 15, 2017
Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell lineJacob J Henderson, Jacob P Wagner, Nicolle E Hofmann, et al.
Pageof 9